Tevogen Bio Holdings Inc. (NASDAQ:TVGN – Get Free Report)’s stock price dropped 1.2% on Tuesday . The stock traded as low as $1.49 and last traded at $1.65. Approximately 102,094 shares were traded during trading, a decline of 67% from the average daily volume of 312,664 shares. The stock had previously closed at $1.67.
Tevogen Bio Price Performance
The stock has a 50 day simple moving average of $4.91.
Tevogen Bio Company Profile
Tevogen Bio Holdings Inc operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID.
Featured Articles
- Five stocks we like better than Tevogen Bio
- Technology Stocks Explained: Here’s What to Know About Tech
- Charles Schwab Fortifies its Uptrend on EPS Beat
- What is the FTSE 100 index?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Best Stocks Under $5.00
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Tevogen Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tevogen Bio and related companies with MarketBeat.com's FREE daily email newsletter.
